April 28, 2021
The Osaka District Court on April 27 made a settlement offer for Ono Pharmaceutical and Kyoto University Prof. Tasuku Honjo in their IP royalty dispute over the anti-PD-1 antibody Opdivo (nivolumab), but talks ended in a rupture with both sides...read more